Pengwei Lv

728 total citations
20 papers, 498 citations indexed

About

Pengwei Lv is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Pengwei Lv has authored 20 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 12 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Pengwei Lv's work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Pengwei Lv is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (8 papers). Pengwei Lv collaborates with scholars based in China and United States. Pengwei Lv's co-authors include Xiaodong Xu, Yan Yu, Xinguang Qiu, Xue Yang, Yuanting Gu, Yunqing Yang, Yuanting Gu, Mingzhi Zhu, Nan Wang and Fang Wang and has published in prestigious journals such as Archives of Biochemistry and Biophysics, Journal of Cellular Biochemistry and Cell Death and Disease.

In The Last Decade

Pengwei Lv

20 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pengwei Lv China	12	380	332	98	45	42	20	498
Dongwei Dou China	13	431 1.1×	355 1.1×	73 0.7×	39 0.9×	36 0.9×	16	518
Ting‐Qing Gan China	15	471 1.2×	420 1.3×	70 0.7×	27 0.6×	60 1.4×	30	578
Chengcheng Ren China	12	514 1.4×	444 1.3×	75 0.8×	34 0.8×	49 1.2×	13	629
Yingchao Ju China	13	439 1.2×	349 1.1×	75 0.8×	57 1.3×	48 1.1×	19	531
Mingchen Zhu China	11	374 1.0×	262 0.8×	76 0.8×	58 1.3×	23 0.5×	26	496
Yuandong Liao China	11	337 0.9×	320 1.0×	90 0.9×	46 1.0×	67 1.6×	19	499
Lydia Beard United States	8	372 1.0×	229 0.7×	101 1.0×	29 0.6×	50 1.2×	10	490
Liyun Luo China	11	428 1.1×	348 1.0×	80 0.8×	31 0.7×	46 1.1×	17	529
Weimei Tang China	13	357 0.9×	199 0.6×	99 1.0×	45 1.0×	73 1.7×	21	447
Mar Haz‐Conde Spain	12	391 1.0×	289 0.9×	126 1.3×	38 0.8×	41 1.0×	14	519

Countries citing papers authored by Pengwei Lv

Since Specialization

Citations

This map shows the geographic impact of Pengwei Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengwei Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengwei Lv more than expected).

Fields of papers citing papers by Pengwei Lv

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengwei Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengwei Lv. The network helps show where Pengwei Lv may publish in the future.

Co-authorship network of co-authors of Pengwei Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Pengwei Lv. A scholar is included among the top collaborators of Pengwei Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengwei Lv. Pengwei Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mao, Xiaoyun, Pengwei Lv, Yiping Gong, et al.. (2022). Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis. Frontiers in Oncology. 12. 855512–855512. 8 indexed citations

Wang, Fang, Xiaochun Wang, Jingruo Li, et al.. (2021). CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling. Journal of Biomedical Science. 28(1). 4–4. 34 indexed citations

Xu, Xiaodong, Xinxing Wang, Dongwei Dou, et al.. (2021). miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome. Cell Death and Disease. 12(4). 350–350. 21 indexed citations

Yang, Xue, Yunqing Yang, Xueke Qian, Xiaodong Xu, & Pengwei Lv. (2021). Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression. Biomedical Journal. 45(3). 512–521. 11 indexed citations

Wang, Fang, Xiaochun Wang, Jingruo Li, et al.. (2021). Correction to: CircNOL10 suppresses breast cancer progression by sponging miR-767-5p to regulate SOCS2/JAK/STAT signaling. Journal of Biomedical Science. 28(1). 31–31. 4 indexed citations

Zhang, Liping & Pengwei Lv. (2021). Research on the Path of Patriotic Education for College Students in the New Era. p20–p20. 2 indexed citations

Lv, Pengwei, Wang Fang, Lin Li, et al.. (2020). Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study. Frontiers in Oncology. 10. 550327–550327. 9 indexed citations

Wang, Yajun, Yong Zhang, Xin Ge, et al.. (2020). Endoplasmic reticulum stress induces growth retardation by inhibiting growth hormone IGF-I axis. Growth Hormone & IGF Research. 55. 101341–101341. 7 indexed citations

Wang, Nan, Lin Li, Fang Wang, et al.. (2019). <p>Long Non-Coding RNA HULC Promotes the Development of Breast Cancer Through Regulating LYPD1 Expression by Sponging miR-6754-5p</p>. OncoTargets and Therapy. Volume 12. 10671–10679. 22 indexed citations

10.

Xu, Xiaodong, et al.. (2019). Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 497–497. 143 indexed citations

11.

Lv, Pengwei, Fang Wang, Lin Li, et al.. (2019). Efficacy, late complications, and cosmetic outcomes of targeted intraoperative radiotherapy in breast-conserving surgery for early-stage breast cancer: a single-centre study in China. Japanese Journal of Clinical Oncology. 49(12). 1120–1125. 7 indexed citations

12.

Han, Mingli, Yimeng Wang, Li Lin, et al.. (2018). microRNA‐30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway. Journal of Cellular Biochemistry. 119(10). 8138–8145. 35 indexed citations

13.

Lv, Pengwei, Xinguang Qiu, Yuanting Gu, et al.. (2018). Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer. Biomedicine & Pharmacotherapy. 110. 294–301. 62 indexed citations

14.

Wang, Nan, Yuanting Gu, Lin Li, et al.. (2018). Circular RNA circMYO9B facilitates breast cancer cell proliferation and invasiveness via upregulating FOXP4 expression by sponging miR-4316. Archives of Biochemistry and Biophysics. 653. 63–70. 33 indexed citations

15.

Li, Lin, et al.. (2018). TOX high mobility group box family member 3 rs3803662 and breast cancer risk. Journal of Cancer Research and Therapeutics. 14(Suppl 1). S208–S212. 7 indexed citations

16.

Wang, Fang, Pengwei Lv, Yuanting Gu, et al.. (2017). Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway. Oncotarget. 8(15). 25097–25106. 20 indexed citations

17.

Lv, Pengwei, et al.. (2016). Pretreatment lymphocyte to monocyte ratio as a predictor of prognosis in patients with early-stage triple-negative breast cancer. Tumor Biology. 37(7). 9037–9043. 20 indexed citations

18.

Wang, Fang, Pengwei Lv, Xinwei Liu, Mingzhi Zhu, & Xinguang Qiu. (2015). microRNA-214 enhances the invasion ability of breast cancer cells by targeting p53. International Journal of Molecular Medicine. 35(5). 1395–1402. 39 indexed citations

19.

Lv, Pengwei, et al.. (2015). Angiotensin II type 1 receptor gene A1166C polymorphism and breast cancer susceptibility. Genetics and Molecular Research. 14(4). 15016–15023. 3 indexed citations

20.

Qiu, Xinguang, et al.. (2014). miR-639 promotes the proliferation and invasion of breast cancer cell in vitro. Cancer Cell International. 14(1). 39–39. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact